3[1]Horwitz DA,Jacob C.The cytokine network in the pathogenesis of systemic lupus erythermatosus and possible therapeutic implications[J].Springer Semin Immunopathol,1994,16(2-3):181-200.
4[2]Rook AH,Kubin M,Cassin M,et al.IL-12 reverses cytokine and immune abnormalities in Sezary Syndrome[J].J Immunol,1995,154(3):1491-1498.
5[3]Claire B, Dafna DG, Murray BU,et al. Derivation of the SLEDAI: a disease activity index for lupus patients[J]. Arthritis Rheum, 1992,35(2):630-640.
6[4]Kobayashi M, Fitz L, Ryan M,et al. Identification and purification of natural killer cell stimulatory factor(NKSF), a cytokine with multiple biologic efects on human lymphocytes[J]. J Exp Med,1989,170(3):827-845.
7[6]Liu TF, Jones BM. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes[J]. Cytokine,1998,10(2):140-147.
8[8]Marshall JD, Secrist H, Dekruyff RH,et al. IL-12 inhibits the production of IL-4 in allergen-specific humen CD+ 4T lymphocytes[J]. J Immunol,1995,18(1):111-117.
9[9]Finkelman FD, Madden KB, Cheever AW,et al. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites[J]. J Exp Med, 1994,179(5):1563-1572.
10[10]Gearing AJ, Newman W. Circulating adhesion molecules in disease[J]. Immunol-Today,1993,14(10): 506-512.
